Other substances

alpha-Hederin

A triterpenoid saponin.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
4
 AI-suggested references
0
 Clinical trials

General information

alpha-Hederin on PubChem

Synonyms

α-Hederin

 

Structure image - alpha-Hederin

C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@]4([C@H]([C@]3(C)CO)CC[C@@]5([C@@H]4CC=C6[C@]5(CC[C@@]7([C@H]6CC(CC7)(C)C)C(=O)O)C)C)C)O)O)O)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Deciphering underlying mechanism of Sars-CoV-2 infection in humans and revealing the therapeutic potential of bioactive constituents from Nigella sativa to combat COVID19: in-silico study
ACE2 Small molecule In silico 		in silico 3.22

Predicted to bind the host ACE2 receptor.

 Oct/28/2020

AI-suggested references

Link Publication date
Phytochemical analysis by GC-MS, LC-MS complementary approaches and antimicrobial activity investigation of Vigna unguiculata (L.) Walp. leaves.
Dec/16/2021
SARS-CoV-2 Inhibitors from Nigella Sativa
Feb/01/2022
Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach.
Sep/08/2021
Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with MPro of SARS-CoV-2 through in silico analysis.
May/21/2021
Export (.csv)